TScan Therapeutics, Inc. TCRX
0.19 USD +0.01 (+5.53%)
At closeNov 3, 2026, 4:00 PM EST
0.18 -0.01 -4.76%
After hours · Nov 3, 4:00 PM ET
0.1768 Day range 0.1954
0.173 52-week range 1.47
- YTD
- -81.10%
- 1 year
- -84.76%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 12.14 +6324.8% upside
Now 0.189
- Target (low)
- 7.00
- Target (mean)
- 12.14
- Target (high)
- 15.00
Ratings (0m) 8 8 buy · 0 hold · 0 sell
- Strong buy4
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.2752 | -0.30 – -0.24 | -0.11 | -150.2% | 1.51M | -79.1% | 5 |
| Next quarter | -0.29 | -0.30 – -0.27 | -0.32 | +9.4% | 1.38M | +144.0% | 3 |
| Current year | -1.12 | -1.15 – -1.08 | -1.36 | +17.5% | 3.60M | -82.9% | 5 |
| Next year | -1.15 | -1.42 – -0.79 | -1.12 | -2.4% | 6.98M | +94.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Dec 11, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 12, 2024 | Needham | Reiterated | Buy | Buy |
| Nov 6, 2024 | Needham | Reiterated | Buy | Buy |
| Aug 13, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 12, 2024 | Needham | Reiterated | Buy | Buy |
| Jun 4, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | BTIG | Initiated | — | Buy |
| May 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 13, 2024 | Needham | Reiterated | Buy | Buy |
| Apr 23, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 7, 2024 | Barclays | Maintained | Overweight | Overweight |
| Mar 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 1, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 14, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 22, 2023 | Wedbush | Initiated | — | Outperform |
| May 18, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 9, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 10, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 16, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 13, 2021 | Cowen & Co. | Initiated | — | Outperform |
| Aug 10, 2021 | Morgan Stanley | Initiated | — | Overweight |
| Aug 10, 2021 | Jefferies | Initiated | — | Buy |